Anticancer Drugs Including The Chemical Structures Of An Androgen Receptor Ligand And A Histone Deacetylase Inhibitor

  • Published: May 8, 2018
  • Earliest Priority: Jan 29 2016
  • Family: 3
  • Cited Works: 38
  • Cited by: 0
  • Cites: 8
  • Additional Info: Cited Works Full text
Abstract

A novel class of drugs for treating androgen receptor (AR) positive cancer including prostate cancer and breast cancer are described. The drugs include the chemical scaffolds of a high affinity androgen receptor ligand and a histone deacetylase inhibitor. Also described are compositions including the novel drugs and methods of treating AR positive cancer using the compositions.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 8, 2018
  • Application: Jan 27, 2017
    US US 201715417860 A
  • Priority: Jan 27, 2017
    US US 201715417860 A
  • Priority: Jan 29, 2016
    US US 201662288810 P

Download Citation


Sign in to the Lens

Feedback